Revealed: countries with most M&A deals in the pharma industry
2022-03-03T21:30:51-05:00Clinical Trials Arena March 3, 2022
Pharma / Biotech
The Innovations of Clinical Trials after the Pandemic
2022-03-03T21:24:55-05:00Managed Healthcare Executive March 3, 2022
Cancer biotech Rondo gets $67M to step on the gas with next-gen bispecific drugs
2022-03-03T21:24:02-05:00MedCity News March 3, 2022
Tech is poised to transform the pharmacy experience for patients
2022-03-03T20:35:04-05:00Healthcare IT News March 3, 2022
CancerIQ raises $14M to grow its platform focused on early detection and prevention
2022-03-03T20:28:04-05:00MedCity News March 3, 2022
Better Insights Management: Q&A with Lance Hill, CEO of Within 3
2022-03-03T20:15:17-05:00Pharmaceutical Executive March 3, 2022
Sacklers agree to new $6bn Purdue US settlement over opioids
2022-03-03T19:47:51-05:00Medical Xpress March 3, 2022
Pharmacogenomics Offers New Roles, Opportunities for Pharmacists
2022-03-03T19:39:03-05:00Pharmacy Times March 3, 2022
Sanofi forges $30m alliance with digital health firm DarioHealth
2022-03-03T17:06:22-05:00pharmaphorum March 3, 2022
Opinion: Inappropriate march-in actions would jeopardize public-private partnerships that make lifesaving medicines possible
2022-03-03T17:03:21-05:00STAT March 3, 2022
Optum’s end game2022-03-03T16:46:55-05:00
Civica targets insulin in effort to produce cheaper drugs
2022-03-03T15:14:04-05:00BioPharma Dive March 3, 2022
Amid biotech downturn, Atlas raises $450M to build new drug startups
2022-03-03T15:13:17-05:00BioPharma Dive March 3, 2022
Biden’s bid to lower drug costs a high priority for stakeholders
2022-03-03T15:10:40-05:00Healthcare Finance News March 3, 2022
Bringing Medication Reconcilliation and Pharmacovigilance from France
2022-03-03T15:07:32-05:00Healthcare IT Today March 3, 2022
Civica plans shake-up of insulin sector with low-cost biosimilars
2022-03-03T14:47:43-05:00pharmaphorum March 3, 2022
Cloud IT, Structural Variants, AI for Cancer, More
2022-03-02T20:58:02-05:00Bio-IT World March 2, 2022
If Medicare Part D Redesign Ever Happens, It Could Lead To Lower Prescription Drug Prices
2022-03-02T20:56:23-05:00Forbes March 2, 2022
Machine learning: Roche is top clinical trial operations innovator in Q4
2022-03-02T17:21:02-05:00Clinical Trials Arena March 2, 2022
Spike Protein Regulates SARS-CoV-2 And Cell Genes2022-03-02T17:10:21-05:00
Price Transparency Or Price Obfuscation? Is A PBM-Backed Network Using Its Monopoly In One Business To Advantage Itself In The Next? (2 Of 2)
2022-03-02T17:09:24-05:00Forbes March 2, 2022
New study shows first FDA-cleared video game treatment for pediatric ADHD improves brain function
2022-03-03T17:09:04-05:00MedCity News March 2, 2022
Price Transparency Or Price Obfuscation? Is A PBM-Backed Network Using Its Monopoly In One Business To Advantage Itself In The Next? (1 Of 2)
2022-03-02T17:08:54-05:00Forbes March 2, 2022
Gene editing biotechs face new uncertainty after CRISPR patent ruling
2022-03-02T16:55:50-05:00BioPharma Dive March 2, 2022